Senior insider sale
Chief R&D Officer at NEKTAR THERAPEUTICS — senior position signals high conviction
$13.0K
199.00 shares
What this filing means
ZALEVSKY JONATHAN plans to sell 199.00 shares of NEKTAR THERAPEUTICS valued at approximately $13.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/19/2026ACC: 0001959173-26-003771
Officer· Chief R&D Officer
Since Oct 2019
199.00
Shares to sell
$13.0K
Approx. market value
199.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/15/2026
199.00Total acquired199.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Vesting Compensation | 199.00 | — |
| Total | 199.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
199.00
Market value
$13.0K
5/19/2026
Total
Units
199.00
Value
$13.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/19/2026 | 199.00 | $13.0K | NASDAQ | Planned |
| Total | 199.00 | $13.0K | ||